We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Actions that trial sponsors should consider to build resilience into clinical trial design
Information on how to request assistance from the NSDR.
The call for applications for phase 2 of the AI Airlock is now closed.
Which product type to select when submitting a notification of intent to market e-cigarette and vape products in Great Britain.
Guidance and advice for community pharmacies in England providing services to people who use drugs and alcohol.
Information relating to the disapplication of falsified medicines under UK Law.
Guidance for medical device manufacturers on when to use electronic instructions and how to comply with the regulations.
Guidance for dispensing of valproate-containing medicines in the manufacturer’s original full pack, following amendments to the Human Medicines Regulations (HMRs).
Provide innovators and developers of innovative products access to MHRA scientific expertise, regulatory guidance and an enhanced advice and signposting service.
To assist sponsors and those conducting trials on implementing adequate oversight and monitoring processes for trials of investigational medical products.
A 5-year voluntary scheme on the control of prices agreed between government and the Association of the British Pharmaceutical Industry (ABPI).
The UK government has introduced the Northern Ireland MHRA Authorised Route (NIMAR). This new route for supply became operational 1 January 2022.
A user guide for understanding and applying the national taxonomy for incident learning in clinical imaging, magnetic resonance imaging and nuclear medicine.
Information for patients, public and healthcare professionals
What you need to do to supply investigational medicinal products (IMPs) from Great Britain to Northern Ireland.
Webinars for pharmaceutical companies, clinical trial sponsors, e-cigarette producers and brokers of medicinal products
How to test and report levels of nicotine uptake when submitting a notification of intent to market e-cigarette and vape products in Great Britain.
This report reviews data on patient doses and equipment trends in dental X-ray imaging procedures between 2014 and 2017.
A document for patients explaining how the highest risk patient groups eligible for new coronavirus treatments will be identified.
Guidance for manufacturers who source their own-branded products from another company.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).